MMWR Morb Mortal Wkly Rep. 2007 Nov 16;56(45):1187-91.
India is one of four countries where wild poliovirus (WPV) transmission has never been interrupted (the others are Afghanistan, Nigeria, and Pakistan). An outbreak of poliomyelitis cases caused by WPV type 1 (WPV1) occurred in India in 2006, primarily in the northern states of Uttar Pradesh and Bihar, where polio remains endemic. This outbreak resulted in the greatest annual number of cases of poliomyelitis in India since 2002. In response, the Government of India and its partners implemented additional vaccination measures based on recommendations from the India Expert Advisory Group on Polio Eradication. These measures focused predominantly on use of monovalent oral poliovirus vaccine type 1 (mOPV1), which has higher efficacy against WPV1 than trivalent OPV (tOPV). As a result, WPV1 cases in India decreased approximately 84% to 66 cases during January-September 2007, compared with 405 cases during the corresponding period in 2006. In western Uttar Pradesh, a state in which multiple risk factors have made interruption of WPV transmission challenging, five WPV1 cases have been reported this year, compared with 299 during the same period in 2006. However, a WPV type 3 (WPV3) outbreak also has been reported, with 261 cases occurring through September 30, 2007, primarily in the northern states where polio remains endemic. This report summarizes progress toward polio eradication in India during January 2006-September 2007 and highlights the challenges and strategic adaptations of eradication measures.
印度是野生脊髓灰质炎病毒(WPV)传播从未被阻断的四个国家之一(其他国家是阿富汗、尼日利亚和巴基斯坦)。2006年,印度发生了由1型野生脊髓灰质炎病毒(WPV1)引起的脊髓灰质炎病例暴发,主要发生在北方邦和比哈尔邦等脊髓灰质炎仍然流行的北方邦。这次疫情导致印度自2002年以来脊髓灰质炎病例数达到年度最高。作为应对措施,印度政府及其合作伙伴根据印度根除脊髓灰质炎专家咨询小组的建议实施了额外的疫苗接种措施。这些措施主要侧重于使用单价口服脊髓灰质炎疫苗1型(mOPV1),其对WPV1的效力高于三价口服脊髓灰质炎疫苗(tOPV)。结果,2007年1月至9月印度的WPV1病例数减少了约84%,降至66例;而2006年同期为405例。在北方邦西部,由于多种风险因素使得阻断WPV传播具有挑战性,今年报告了5例WPV1病例,而2006年同期为299例。然而,也报告了3型野生脊髓灰质炎病毒(WPV3)疫情,截至2007年9月30日共发生261例,主要发生在脊髓灰质炎仍然流行的北方邦。本报告总结了2006年1月至2007年9月印度在根除脊髓灰质炎方面取得的进展,并强调了根除措施面临的挑战和战略调整。